Company Analysis
Sign in

IDEAYA Biosciences, Inc. (IDYA)

Nasdaq: IDYA · Pharmaceutical Preparations · South San Francisco, CA · filing with the SEC since 2016
Full chart Alerts Compare
Grade6.4
◀ Past 5.4● Present 7.1▶ Future 6.5
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

14 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to IDEAYA Biosciences, Inc.’s names, not what it holds today.

Patents granted
14
14 utility, 1976 to Dec 31, 2025
Granted in 2025
5
Against 1 in 2024 and 2 in 2023
Applications published
36
7 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Organic fine chemistry9
Pharmaceuticals4
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
IDEAYA BIOSCIENCES, INC. its own name
named as the applicant on its applications, in US
0 granted
34 published
IDEAYA Biosciences, Inc. its own name
US, as the owner printed on each patent
14 granted
2 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 30, 202512,509,454Thiadiazolyl derivativesOrganic fine chemistryIDEAYA Biosciences, Inc.
Dec 23, 202512,503,4672-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitorsOrganic fine chemistryIDEAYA Biosciences, Inc.
Aug 26, 202512,398,131Thiadiazolyl derivatives as DNA polymerase theta inhibitors and uses thereofPharmaceuticalsIDEAYA Biosciences, Inc.
Apr 8, 202512,269,820Piperazine substituted indazole compounds as inhibitors of PARGOrganic fine chemistryIDEAYA Biosciences, Inc.
Mar 25, 202512,258,354AhR modulatorsOrganic fine chemistryIDEAYA Biosciences, Inc.
Oct 15, 202412,115,163Combination therapy comprising a MAT2A inhibitor and a type II PRMT inhibitorPharmaceuticalsIDEAYA Biosciences, Inc.
Feb 21, 202311,584,755Dihydrothieno[3,2-b]pyridine compoundsPharmaceuticalsIDEAYA Biosciences, Inc.
Jan 10, 202311,548,867Amido compounds as AhR modulatorsOrganic fine chemistryIDEAYA Biosciences, Inc.
Dec 20, 202211,530,220Substituted imidazo[1,5-a]pyrazines and [1,2,4]triazolo[4,3-a]pyrazines for the modulation of AhRPharmaceuticalsIDEAYA Biosciences, Inc.
Aug 9, 202211,407,764AhR modulatorsOrganic fine chemistryIDEAYA Biosciences, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 11, 20252025/0376467PIPERAZINE SUBSTITUTED INDAZOLE COMPOUNDS AS INHIBITORS OF PARGOrganic fine chemistryIDEAYA BIOSCIENCES, INC.
Nov 13, 20252025/0346591THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS AND USES THEREOFPharmaceuticalsIDEAYA Biosciences, Inc.
Nov 13, 20252025/0346590THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS AND USES THEREOFPharmaceuticalsIDEAYA Biosciences, Inc.
Oct 23, 20252025/0325552SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORSPharmaceuticalsIDEAYA BIOSCIENCES, INC.
Jul 31, 20252025/0243188METHIONINE ADENOSYLTRANSERASE 2A INHIBITORSOrganic fine chemistryIDEAYA BIOSCIENCES, INC.
Mar 20, 20252025/0090533COMBINATION THERAPY COMPRISING A MAT2A INHIBITOR AND A TAXANEPharmaceuticalsIDEAYA BIOSCIENCES, INC.
Jan 16, 20252025/0017921PHARMACEUTICAL COMBINATION AND TUMOR TREATMENTPharmaceuticalsIDEAYA BIOSCIENCES, INC.
Oct 10, 20242024/0335440COMBINATION THERAPY COMPRISING A PKC INHIBITOR AND A C-MET INHIBITORPharmaceuticalsIDEAYA BIOSCIENCES, INC.
Oct 3, 20242024/0327399THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS AND USES THEREOFPharmaceuticalsIDEAYA BIOSCIENCES, INC. · patent 12,398,131 granted from it
Aug 29, 20242024/0287080O-LINKED THIADIAZOLYL COMPOUNDS AS DNA POLYMERASE THETA INHIBITORSOrganic fine chemistryIDEAYA BIOSCIENCES, INC.
What it applied for, 2024 to 2025: Pharmaceuticals 11 · Organic fine chemistry 4.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton IDYA · research, not advice